Artículos de interés
EVOLUCIÓN DE LA DEFINICIÓN DE DISPLASIA BRONCOPULMONAR Y DE SUS CRITERIOS DIAGNÓSTICOS: PRINCIPALES ESTUDIOS
- Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach.
- Bronchopulmonary Dysplasia: Executive Summary of a Workshop
- Bronchopulmonary dysplasia: definitions and classifications.
- Impact of a physiologic definition on bronchopulmonary dysplasia rates.
- Bronchopulmonary displasia. NICHD/NHLBI/ORD Workshop Summary.
- Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period.
- Bronchopulmonary dysplasia: clinical presentation.
PREVENCIÓN Y DBP
- Noninvasive Ventilation With vs Without Early Surfactant to Prevent Chronic Lung Disease in Preterm Infants A Systematic Review and Meta-analysis.
- Less Invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress sindrome: a systematic review and meta-analysis
- Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
- A Comprehensive Approach to the Prevention of Bronchopulmonary Dysplasia.
- A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants.
- An update on pharmacologic approaches to bronchopulmonary displasia.
- Drug therapy for the prevention and treatment of bronchopulmonary dysplasia.
- Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions.
- Azithromycin and Other Macrolides for Prevention of Bronchopulmonary Dysplasia: A SystematicReview and Meta-Analysis.
ENSAYOS CLÍNICOS RECIENTES
- Nebulized pentoxifylline for reducing the duration of oxygen supplementation in extremely preterm neonates.
- Late surfactant administration in very preterm neonates with prolonged respiratory distress and pulmonary outcome at 1 year of age a randomized clinical trial.
- Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia.
- Early inhaled budesonide for the prevention of bronchopulmonary dysplasia.
CORTICOSTEROIDES POSTNATALES Y DBP
- Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants
- Update on Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia
- Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial